• Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Awards
  • Join
  • Sign in
Skip to content
Cannabiz

Cannabiz

The Business of Cannabis

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Awards
  • Join
  • Sign in
Home ยป Joel Latham

Tag: Joel Latham

Company news: Medicinal Harvest; Cannasouth/Eqalis; Cann Group; MGC Pharma; Incannex; Neurotech

by Martin Lane May 3, 2023August 16, 2023

Contract cultivator Medicinal Harvest is building additional indoor cultivation space at its South-East Queensland facility that […]

Company news: Helius Therapeutics; Little Green Pharma; MGC Pharma; Incannex

by Martin Lane and Steve Jones December 7, 2022December 7, 2022

Incannex secures A$13m placement but share price dives

by Steve Jones December 5, 2022December 8, 2022

Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria

by Martin Lane October 20, 2022August 16, 2023

Company news: MediCann Health; Creso Pharma; Botanix Pharmaceuticals; Incannex

by Martin Lane September 7, 2022August 16, 2023

Incannex receives ethics approval for phase one clinical trial of CBD-based anti-inflammatory drug

by Martin Lane July 22, 2022August 16, 2023

Dr Sud Argawal steps down from Incannex board

by Martin Lane June 28, 2022June 29, 2022

Incannex progresses APIRx acquisition

by Martin Lane May 13, 2022August 16, 2023

Company news: Medigrowth; Greenfern Industries; Incannex; Cannatrek; MediPharm Labs; Cresco Labs

by Martin Lane March 24, 2022August 16, 2023

Company news: Emyria; Incannex; Epsilon; AusCann

by Martin Lane March 8, 2022August 16, 2023

Posts navigation

1 2 Older posts

My Account

Sign in

Category

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards

About

  • About/contact us
  • Join
  • Sign in
  • Privacy Policy
  • Website Terms & Conditions
  • Membership Terms & Conditions
  • Submit a Guest Post
  • About cannabis
  • Editorial policy
Cannabiz
  • Facebook
  • Linkedin
  • Instagram
  • X
© 2023 Cannabiz.